While Akzo reported strong Q1FY24 led by strong growth across segments, we are enthused by board recommendation to re-appointment Mr. Rajiv Rajgopal as MD for five years. Rajiv had turned around Akzo Nobel India and initiated multiple investments such as increase in distribution and portfolio expansion.